StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Renalytix's ebitda for the twelve months ending Sep 30, 2024 was -$24.52M. For fiscal 2024 it was -$29.24M. The highest annual figure on record is -$10.25M in fiscal 2020.

Annual ebitda

PeriodPeriod endValueChange
FY2024Jun 30, 2024-$29.24M–
FY2023Jun 30, 2023-$41.71M–
FY2022Jun 30, 2022-$52.69M–
FY2021Jun 30, 2021-$31.63M–
FY2020Jun 30, 2020-$10.25M–
FY2019Jun 30, 2019-$42.31M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2025CQ3 2024Sep 30, 2024-$4.03M–
Q4 FY2024CQ2 2024Jun 30, 2024-$5.47M–
Q3 FY2024CQ1 2024Mar 31, 2024-$6.48M–
Q2 FY2024CQ4 2023Dec 31, 2023-$8.53M–
Q1 FY2024CQ3 2023Sep 30, 2023-$8.76M–
Q4 FY2023CQ2 2023Jun 30, 2023-$9.81M–
Q3 FY2023CQ1 2023Mar 31, 2023-$10.79M–
Q2 FY2023CQ4 2022Dec 31, 2022-$9.52M–
Q1 FY2023CQ3 2022Sep 30, 2022-$11.59M–
Q4 FY2022CQ2 2022Jun 30, 2022-$12.92M–
Q3 FY2022CQ1 2022Mar 31, 2022-$14.41M–
Q2 FY2022CQ4 2021Dec 31, 2021-$13.68M–
Q1 FY2022CQ3 2021Sep 30, 2021-$11.70M–
Q4 FY2021CQ2 2021Jun 30, 2021-$9.73M–
Q3 FY2021CQ1 2021Mar 31, 2021-$7.99M–

More Renalytix figures

See a number that looks wrong?